Characteristics of Subjects Who Avoid Activities and Participation due to a Fear of Falling in Parkinson’s Disease by Lopker, Morgan & Newman, Molly
UNLV Theses, Dissertations, Professional Papers, and Capstones
Spring 5-2014
Characteristics of Subjects Who Avoid Activities
and Participation due to a Fear of Falling in
Parkinson’s Disease
Morgan Lopker
University of Nevada, Las Vegas
Molly Newman
University of Nevada, Las Vegas
Follow this and additional works at: http://digitalscholarship.unlv.edu/thesesdissertations
Part of the Behavior and Behavior Mechanisms Commons, and the Physical Therapy Commons
This Professional Paper is brought to you for free and open access by Digital Scholarship@UNLV. It has been accepted for inclusion in UNLV Theses,
Dissertations, Professional Papers, and Capstones by an authorized administrator of Digital Scholarship@UNLV. For more information, please contact
digitalscholarship@unlv.edu.
Repository Citation
Lopker, Morgan and Newman, Molly, "Characteristics of Subjects Who Avoid Activities and Participation due to a Fear of Falling in
Parkinson’s Disease" (2014). UNLV Theses, Dissertations, Professional Papers, and Capstones. 2458.
http://digitalscholarship.unlv.edu/thesesdissertations/2458
 
 
 
 
CHARACTERISTICS OF SUBJECTS WHO AVOID ACTIVITIES  
AND PARTICIPATION DUE TO A FEAR OF FALLING 
 IN PARKINSON'S DISEASE 
By 
Morgan Lopker 
Molly Newman 
 
A doctoral project submitted in partial fulfillment 
of the requirements for the 
 
Doctorate of Physical Therapy 
 
Department of Physical Therapy 
School of Allied Health Sciences 
The Graduate College 
 
University of Nevada, Las Vegas 
May 2014 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright by Morgan Lopker and Molly Newman, 2014 
All Rights Reserved.
 ii 
 
  
 
THE GRADUATE COLLEGE 
 
We recommend the doctoral project prepared under our supervision by  
Morgan Lopker and Molly Newman 
entitled  
Characteristics of Subjects Who Avoid Activities and Participation due 
to a Fear of Falling in Parkinson’s Disease 
is approved in partial fulfillment of the requirements for the degree of 
Doctor of Physical Therapy 
 Department of Physical Therapy  
 
 
Kai-Yu Ho, Ph.D., Research Project Coordinator 
Merrill Landers, Ph.D., Research Project Advisor 
Merrill Landers, Ph.D., Chair, Department Chair Physical Therapy 
Kathryn Hausbeck Korgan, Ph.D., Interim Dean of the Graduate College 
 
May 2014 
 
 
 iii 
 
 ABSTRACT 
Background and Purpose: The purpose of this study was to compare individuals with 
Parkinson’s disease (PD) exhibiting fear of falling avoidance behavior to those with no 
fear of falling avoidance behavior.  Because avoidance behavior can have deleterious 
downstream consequences, it is important to determine what potentially mitigated 
physical and psychological factors are associated with it. 
Subjects: Fifty-six community dwelling individuals (age=72.1 years, SD=9.6; males=42, 
females=14) with PD (Hoehn and Yahr Scale stage median=2.0, mode=3.0) were 
classified into two groups using the Fear of Falls Avoidance Behavior Questionnaire 
(FFABQ): avoiders (n=26, ≥20 FFABQ), and non-avoiders (n=30, <20 on the FFABQ). 
Methods: Avoiders and non-avoiders were compared using five domains: demographics 
(age, gender, socioeconomic status (SES), education), PD (Parkinson’s Unified 
Parkinson’s Disease Rating Scale (MDS-UPDRS), Hoehn and Yahr Scale, Parkinson’s 
Disease Questionnaire (PDQ-39)), balance and falls (fall history, Berg Balance Scale 
(BBS), Activities Specific Balance Scale (ABC)), physical performance (2-minute step 
test (2MST), 30 second Sit to Stand Test (30STS), Timed Up and Go Test (TUGT), 
ActivPAL physical activity monitor data), and psychological factors (Zung Anxiety Scale 
(ZAS), Beck Depression Inventory (BDI)). 
Results: There were no differences between avoiders and non-avoiders in age, gender, 
SES, education, year of diagnosis, and fall history, including injurious falls (ps>0.272).  
Avoiders had worse scores on the MDS-UPDRS (sections I-III, ps<0.014) and the PDQ 
(mobility, ADLs, emotion, stigma, cognition, and bodily discomfort subscales, 
ps<0.028).  Avoiders also exhibited poorer balance performance and less balance 
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confidence (BBS, p=0.003; ABC, p<0.001; FES, p=0.048). Avoiders reported higher 
depression, anxiety, and catastrophization (BDI, p=0.015; ZAS, p=0.028; CAFS, 
p=0.001; CoFQ, p<0.001). 
Discussion:  Results of this study suggest that individuals with PD who report higher 
avoidance behaviors have more involved PD symptoms, score lower for balance, strength 
and conditioning, and have greater psychological distress, including depression, anxiety, 
and catastrophization.  There were no differences in fall history between the two groups, 
presumably because avoiders may have avoided activities that increase the risk for a 
potential fall.  While these findings suggest that avoidance behavior has both physical 
and psychological dimensions, the cause-effect relationship cannot be determined. 
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INTRODUCTION 
Falling is a major problem among those with Parkinson’s disease (PD) where 60.5% fall 
annually and 39% are recurrent fallers with an average fall rate of 20.8 times per year.
1
  
Falls in those with PD are associated with decreased function and quality of life, an 
increased risk of hospital/nursing home admission, and increased mortality.
2-4
  Recurrent 
falls substantially increase the likelihood of injury and long-term disability.
5
  Allen et al 
found that fall history, longer PD history, increased motor impairment, and fear of falling 
(FOF) were factors associated with recurrent falling.
1
  
 
Fear of falling can easily develop among the general elderly population after 
experiencing a fall, with about one-third developing FOF after a fall event.
6
 
 
However, 
Howland et al
7
 found that a recent fall is not necessary in developing FOF, with 20% of 
older individuals reporting a FOF without a recent fall, and among those with PD, a FOF 
appears to be unrelated to fall history.
8
  Individuals with PD who have FOF are estimated 
to be 35-59%, and as many as 70% of people with PD acknowledge activity avoidance 
due to a FOF.
9-15  
Fear of falling can lead to worry, low balance confidence, and activity 
avoidance, and may affect social interaction, which leads to disability.
7,14
 
 
Up to three-quarters of all adults 65 and older avoid at least one activity due to FOF, with 
15% reporting severe activity restrictions.
16
  It is thought that catastrophization, or 
focusing on the worst possible outcome, can be the root of avoidance behavior and has 
been described as a leading cause of disability.
17,18
  While avoidance due to a FOF may 
initially decrease the chances of a fall, decreasing activity leads to lower activity 
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tolerance and functional ability.  The cycle of falling and FOF is propagated by impaired 
balance due to inactivity and postural instability in those with PD.
9,19
  Fear of falling can 
lead to various levels of activity avoidance by people, which can be described as non-
avoiders and avoiders.
19
  Impaired balance due to inactivity, coupled with postural 
instability, perpetuates the cycle of falling and FOF in individuals with PD.
9,19
 
  
Avoiders may have a lower quality of life due to their decreased participation in activities 
of daily living.  Understanding the role of fear-based avoidance of activities, and its 
relationship to activity and function is an important topic that has received little attention 
in the PD literature.  Understanding this phenomenon may help to develop more effective 
rehabilitative treatment plans for people with PD.  The purpose of this study was to 
examine FOF avoidance behaviors in people with PD and to identify possible differences 
between non-avoiders and avoiders in six different domains: demographics domain, PD 
domain, balance and fall domain, physical performance domain, and psychological 
domain.  By identifying common characteristics among people with PD and high 
avoidance behavior, individualized treatments can be better administered and lead to 
improved treatment outcomes.
19,20  
Ultimately, this study hopes to identify modifiable and 
non-modifiable characteristics of high avoiders. 
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METHODS 
Subjects 
Fifty-six community dwelling individuals (age mean = 72.1 years, SD = 9.6; males = 42, 
females = 14) with neurologist-diagnosed idiopathic PD (Hoehn and Yahr Scale score 
median = 2.0, mode = 3.0) participated in this study.  Participants were excluded if they 
were unable to read or speak English (n = 0), non-compliance (n = 1), had cognitive 
impairment (Mini-Mental State Exam score < 23 (n = 4)), or if they had comorbidities 
that significantly impaired balance (n = 0).  Subjects were from local PD support groups 
via print ads and snowball recruitment.   
 
Study Design 
A prospective, cross-sectional research design was used to compare the characteristics of 
subjects with PD who were classified as having moderate/high avoidance behavior 
(avoiders) or low-avoidance behavior (non-avoiders) as a result of FOF.  The Fear of 
Falling Avoidance Behavior Questionnaire (FFABQ)
21
 was used to dichotomize subjects 
into avoider and non-avoider groups (Table 1).  
The FFABQ is based on the construct of avoidance behavior due to FOF and is a separate 
and distinct construct from measures of balance confidence, self-efficacy, and FOF.
21
  
This questionnaire consists of 14 Likert scale items (completely disagree, disagree, 
unsure, agree, completely agree) related to the International Classification of 
Functioning, Disability, and Health (ICF) on the participation level.  Scores range from 0 
to 56 with higher scores indicative of more avoidance behavior.  A score of 20 was 
determined to be the cut-point (avoiders ≥ 20; non-avoiders < 20), because an overall 
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score of 20 for the 14 items indicates that the average response for each item would fall 
into the range of “Completely disagree” or “Disagree.”  In order to compare the avoiders 
and non-avoiders, subjects were assessed across the following five domains:  
1. Demographic domain:  this domain was used to determine if demographic 
characteristics (e.g., age, gender, socioeconomic status (income per year), 
educational attainment, and year of diagnosis) were associated with avoidance 
behavior; 
2. PD domain:  this domain included the Movement Disorder Society-Unified 
Parkinson’s Disease Rating Scale (MDS-UPDRS), Hoehn and Yahr Scale, and 
Parkinson’s Disease Questionnaire (PDQ-39) (Table 2); 
3. Balance and fall domain:  this domain included items about subjects’ fall history 
that could logically be associated with avoidance behavior (fall history = more 
than one unexplained fall during the most recent year, recent falls = number of 
falls during the most recent month, fall injury = number of falls resulting in an 
injury) and also scales of balance performance (Berg Balance Scale (BBS)), 
balance confidence (Activities-Specific Balance Confidence Scale (ABC) and 
Falls Efficacy Scale (FES)), psychological impact of a fall (Impact of Events 
Scale (IES)), and fall catastrophization (Consequences of Falls Questionnaire 
(CoFQ) and Catastrophization about Falls Scale (CAFS) (Table 3); 
4. Physical performance domain:  this domain was used to understand subjects’ 
current state of strength and conditioning (Two Minute Step Test (2MST), 30 
Second Sit to Stand Test (30STS)), functional mobility (Timed-Up and Go Test 
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(TUGT)), and average daily physical activity levels using activPAL monitors
1
 
(Metabolic equivalents (METS) expended, time sitting or lying, time standing, 
time stepping, number of steps taken, and up/down transitions) (Table 4); and, 
5. Psychological domain:  this domain was used to determine the role of other 
psychological constructs putatively associated with the consequences of 
experiencing a fall or having balance impairment (Zung Anxiety Scale (ZAS) and 
Beck Depression Inventory (BDI)) (Table 5).   
Data for all subjects were collected at the subjects’ residence since it was theorized that 
many high avoiders would be reluctant to leave their homes for participation in a study.  
Subjects were assessed twice: once for the initial assessment and once approximately one 
week later to collect the activity monitor and self-report questionnaires (Figure 1). 
 
Data Analysis 
All data were analyzed using SPSS version 21.0.
2
  The level of significance for all of the 
analyses was set at α = 0.05.  Avoiders and non-avoiders were compared using t-tests for 
all parametric variables unless there was a violation of an assumption wherein a Mann-
Whitney nonparametric analysis was used.  Mann-Whitney analyses were also utilized 
for dependent variables at the ordinal measurement level.  Chi-square was used to 
compare gender proportions. 
 
 
 
                                                          
1
PAL Technologies LTD, Glasgow, United Kingdom 
2
 SPSS Inc, Chicago, Illinois 
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RESULTS 
Demographic domain 
There were no differences between avoiders and non-avoiders in age, gender, SES, 
education, year of PD diagnosis, and mental status (ps>0.221) (Table 1).   
 
PD domain   
Avoiders had worse scores on the MDS-UPDRS (sections I-III, ps<0.014) and the PDQ-
39 (mobility, ADLs, emotion, stigma, cognition, and bodily discomfort subscales, 
ps<0.028) (Table 1).  No statistically significant differences were found between avoiders 
and non-avoiders in the following variables: MDS-UPDRS section IV, Hoehn & Yahr 
score, PDQ Social support, PDQ Communication (p>0.14)(Table 1; Figures 2,3). 
 
Balance and fall domain 
While there were no differences between avoiders and non-avoiders in fall history and 
injurious falls (ps≥0.292), avoiders exhibited significantly poorer balance performance 
(BBS, p=0.003) (Table 1; Figure 4).  Additionally, avoiders reported less balance 
confidence (ABC, p<0.001; FES, p=0.048) and were more likely to catastrophize about 
falls (CoFQ, p≤0.001; CAFS, p=0.001) (Table 1; Figure 5).  For individuals reporting a 
fall history (avoiders n=22; non-avoiders n=18), the IES was used to explore the 
subjective impact of a traumatic event (i.e., fall/falls).  Avoiders exhibited greater total 
subjective stress (p=0.018) and more feelings of intrusion (p=0.006), avoidance 
(p=0.050), and hyperarousal (p=0.023) from the fall/falls (Table 1; Figure 6). 
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Physical performance domain 
There were no differences between avoiders and non-avoiders on the TUGT (p=0.100) 
and the 2MST (p=0.110); however, avoiders had fewer completions on the 30STS test 
(p=0.029) (Table 1; Figure 7).  Average daily activity levels (hours stepping per day, 
steps taken in a day, METs per day) were lower for avoiders (ps≤0.018) (Table 1; Figure 
8). 
Psychological domain 
Avoiders reported more depressive symptoms (BDI, p=0.015) and anxiety (ZAS, 
p=0.028) than non-avoiders (Table 1; Figure 9).   
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DISCUSSION 
These results indicate that individuals with PD who report higher avoidance behaviors 
have more involved PD symptoms, reduced scores for balance and physical performance, 
as well as greater psychological distress, including depression, anxiety, and 
catastrophization. There were no differences in fall history between the two groups 
despite the fact that avoiders had lower balance performance and lower balance 
confidence.  It is theorized that avoiders may be naturally responding to their own sense 
of balance confidence by avoiding activities that put them at risk for a fall.  While these 
findings suggest that avoidance behavior has both physical and psychological 
dimensions, the cause-effect relationship cannot be determined. Therefore, it is unclear 
whether the avoidance behavior has caused these symptoms or if these symptoms have 
caused the avoidance behavior. 
 
Demographic profiles of the individuals in the two groups were found to be similar 
between avoiders and non-avoiders, with no significant between group difference in age, 
SES, education, or year of diagnosis.  As such, the results suggest that these non-
modifiable demographic factors are not the primary contributors to FOF avoidance 
behaviors.    
 
The MDS-UPDRS overall score, and mental, ADL, and motor subscales were 
significantly different between avoiders and non-avoiders.  The difference in subjective 
mental measures include memory, cognition, hallucinations, anxiety, depression, bowel 
and bladder complications, pain, fatigue, and apathy.  The differences between the two 
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groups suggest that these non-motor aspects of PD that increase with disease progression
8
 
are also likely to play a role in FOF avoidance behavior.  On the other hand, it is possible 
that these symptoms may indicate disease severity and are not directly related to FOF 
avoidance behavior.  In consideration of the former, addressing these factors with 
pharmacotherapeutic approaches may lead to decreased activity avoidance and a resultant 
increase in QOL of individuals with PD.  The ADL subscale is the one section of the 
MDS-UPDRS that is completely self-reported.  The significantly higher scores in the 
avoiders compared to the non-avoiders supports their awareness of their impaired 
function and/or their lack of confidence in their ability to perform various ADLs.  The 
difference between the avoiders and non-avoiders in the motor subsection of the MDS-
UPDRS including key motor symptoms of PD of rigidity, resting tremor, bradykinesia, 
akinesia, and postural instability indicates a potential role of increasing severity of these 
symptoms on FOF and resultant avoidance of activities.  Again, it is difficult to ascertain 
if these motor have caused the FOF avoidance behavior or if the avoidance behavior has 
caused the neurodegeneration to progress more rapidly.  Several studies suggest that 
physical inactivity can increase the risk for PD
22,23
 and increase the rate of PD 
progression.
24-26
 
 
While Masud et al
9
 reported approximately one third of older people develop FOF after 
an incidental fall, not all people who have a FOF have a history of falls, and not all 
people with a history of falls have a FOF.  According to Howland et al,
10
 20% of 
individuals without a recent history of falls reported to be very or somewhat afraid of 
experiencing a fall.  When compared to experiencing an actual fall, the FOF may be more 
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problematic and a greater contributor to activity avoidance for individuals with or without 
a fall history.
10–12  
The lack of a difference in the current study’s results found in fall 
history (number of falls within the past year, number of falls within the past month, and 
total number of falls resulting in injury) is consistent with this notion. The results support 
other previous findings that FOF and related avoidance behaviors are not the direct result 
of a prior incident and are multifactorial. 
 
Activity avoidance minimizes participation in common tasks that would require normal 
body movements such as weight-bearing, weight-shifting, and reaching outside one’s 
base of support.  An inverse relationship was found between FOF avoidance level and 
subjective, self-report balance questionnaire scores, including the ABC.  Clinically, 
balance confidence may be an important, potentially modifiable target for health care 
providers to assess and treat in PD.  Evidence suggests that clinical-setting balance 
confidence can be improved with skilled intervention.
14
 
 
As functional balance declines, a person is more likely to cope with their lack of balance 
by avoiding the tasks that challenge balance altogether.
15
 Consequently, a reduction in 
activity due to FOF, poor balance, and low balance confidence may contribute to physical 
deconditioning, functional decline, social isolation, and decreased QOL, which are 
factors correlating with increased fall incidence.  The results of this study suggest that PD 
avoiders are indeed less physically conditioned as is evidenced by lower 30STS scores.  
Again, based on the design of the present study, it is difficult to determine if the 
deconditioning is a cause of the avoidance behavior or the result thereof.  It is also 
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possible that this relationship could be bidirectional, which would result in a vicious 
cycle. 
 
Although the findings of the 30STS suggest a relationship between strength and FOF 
avoidance behavior classification, other measures, including TUGT and 2MST, do not.  
While 2MST requires single leg balance and functional lower extremity range of motion, 
its ability to be used as an isolated measure of strength may be limited.  A potential floor 
and ceiling effect of the TUGT may exist in this study cohort. However, future large-
scale studies would be necessary to examine the relationship between FOF and physical 
performance. 
 
All psychological factors utilized in this study assessed were different between the two 
groups.  This finding is supported by the finding by Howland et al
17
 who suggests that 
activity avoidance is not just associated with extreme levels of fear but rather is complex 
and multifactorial.  Previous research, including Lachman et al,
18
 has proposed a  
multidimensional treatment approach for addressing fall risk.  This approach may entail 
assessment of avoidance behaviors, anxiety, and depression, while attempting to alter a 
person’s sense of control over falls through cognitive restructuring.  The findings of the 
present study support this approach and of approaches utilizing physical and 
psychological interventions for FOF avoidance behaviors.   
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CONCLUSION 
This study suggests that individuals with PD who show higher avoidance behaviors 
report more involved PD symptoms, reduced  scores of balance and physical 
performance, as well as greater psychological distress, including depression, anxiety, and 
catastrophization.  Avoidance behaviors in individuals with PD have not been found to be 
a direct consequence of a fall incident and resultant fear of future falls but rather have 
been demonstrated to be multifactorial. This study suggests that when treating patients 
with PD, the contributing factors to patients’ FOF avoidance behaviors outlined 
previously should be taken into consideration.  Further research is needed to confirm 
whether modifiable factors (physical performance, balance, balance confidence) 
identified in this study can be improved with rehabilitative treatment.   
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APPENDIX A- TABLES 
Table 1.  Comparisons of avoiders and non-avoiders using t-tests with means (standard 
deviations) of the five domains.  Several analyses were conducted using non-parametric 
analyses (indicated).  In those cases, medians (ranges) and frequencies are included. 
Domains Dependent variables 
Non-
Avoiders 
N=30 
Avoiders 
N=26 
Analysis P value 
Demographic 
domain 
Age 71.5 (9.4) 72.7 (9.9) t-test 0.636 
Gender 24 males (80.0%) 18 males (69.2%) Chi square 0.353 
Socioeconomic Status (SES) $50-75,000 $50-75,000 Mann-
Whitney* 
0.914 
Education BA/BS degree Some college Mann-
Whitney* 
0.321 
Diagnosis year 2005.8 (4.2) 2004.4 (4.8) t-test 0.272 
Mini-Mental State Exam 29.1 (1.3) 28.7 (1.2) t-test 0.221 
Parkinson’s disease subtype PIGD (55.2%) PIGD (69.2%) Chi square 0.109 
PD domain 
Movement Disorders Society (MDS)-UPDRS 58.5 (28.4) 82.2 (21.5) t-test 0.001
# 
     MDS-UPDRS I (non-motor experiences of 
daily living) 
12.0 (7.1) 17.3 (5.9) t-test 0.005# 
     MDS-UPDRS II (motor experiences of 
daily living) 
14.5 (8.6 22.3 (7.5) t-test 0.001# 
     MDS-UPDRS III (Motor) 26.8 (15.6) 37.0 (14.2) t-test 0.014
# 
     MDS-UPDRS IV (Motor complications) 5.2 (4.4) 5.6 (4.8) t-test 0.752 
Hoehn & Yahr 3.0 (40.0%) 3.0 (46.2%) Chi square 0.440 
Parkinson’s Disease Questionnaire (PDQ)-39 22.7 (13.7) 36.3 (14.2) t-test 0.001
# 
     PDQ Mobility 25.2 (22.1) 50.0 (20.9) t-test <0.001
# 
     PDQ ADLs 23.6 (21.3) 41.4 (20.9) t-test 0.003
# 
     PDQ Emotion 18.7 (14.4) 29.2 (18.4) t-test 0.021
# 
     PDQ Stigma 11.0 (13.8) 22.1 (19.9) t-test 0.018
# 
     PDQ Social support 16.1 (15.8) 22.1 (24.0) t-test 0.268 
     PDQ Cognition 28.1 (22.5) 40.4 (17.2) t-test 0.028
# 
    PDQ Communication 32.5 (23.3) 41.3 (20.5) t-test 0.140 
    PDQ Bodily discomfort 25.8 (20.2) 42.6 (24.7) t-test 0.007
# 
Balance and 
fall domain 
Falls in the last year 8.4 (24.8) 16.6 (68.1) Mann-
Whitney* 
0.292 
Falls in the last month 3.6 (15.5) 1.4 (5.9) Mann-
Whitney* 
0.513 
Injurious falls in the last year  0.6 (1.6) 0.4 (0.6) Mann-
Whitney* 
0.700 
Impact of Events Scale – revised 1.73 (2.00) 3.38 (2.21) t-test 0.018
# 
     Impact of Events Scale – avoidance 0.63 (0.73) 1.11 (0.79) t-test 0.050
# 
     Impact of Events Scale – intrusion 0.57 (0.71) 1.28 (0.81) t-test 0.006
# 
     Impact of Events Scale – hyperarousal 0.53 (0.68) 1.10 (0.81) t-test 0.023
# 
Berg Balance Scale 47.8 (11.8) 38.3 (10.5) t-test 0.003
# 
Activities-Specific Balance Confidence Scale 73.7 (23.8) 50.9 (19.6) t-test <0.001
# 
Consequences of Falls Questionnaire 24.6 (5.0) 30.7 (5.2) t-test <0.001
# 
Falls Efficacy Scale 22.4 (16.2) 33.4 (24.2) t-test 0.048
# 
Catastrophizing about Falls Scale 5.4 (2.1) 7.4 (1.8) t-test 0.001
# 
Physical 
performance 
domain 
2-minute Step Test 57.8 (36.8) 41.5 (37.1) t-test 0.110 
30 Second Sit-To-Stand Test 10.8 (7.4) 6.8 (5.6) t-test 0.029
# 
Timed Up and Go Test 12.1 (6.2) 20.7 (27.0) t-test 0.100 
Hours sitting/laying down per day 18.7 (1.9) 19.7 (3.1) t-test 0.219 
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Hours standing per day 4.2 (1.5) 3.4 (2.2) t-test 0.144 
Hours stepping per day 1.2 (0.6) 0.7 (0.8) t-test 0.018
# 
Steps taken in a day 5798 (2580) 3381 (3878) t-test 0.011
# 
Up/down transitions 51.6 (12.4) 46.5 (21.6) t-test 0.324 
Metabolic equivalents (METs) per day 32.8 (1.1) 31.8 (1.7) t-test 0.017
# 
Psychological 
domain 
Zung Anxiety Scale 43.3 (9.8) 49.2 (9.6) t-test 0.028
# 
Beck Depression Inventory 9.6 (6.9) 15.2 (9.7) t-test 0.015
# 
*Violation of an assumption of normal distribution or non-parametric dependent variable 
 
# Indicates a significant difference at p <0.05   
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Table 2.  Parkinson’s disease domain variables. 
Scale Construct 
Evidence for 
reliability 
Evidence for 
validity in PD 
MDS-
UPDRS27 
65 item clinical rating scale for PD including 
interview, clinician rating and self-assessment 
of PD severity that has 4 parts: I. Non motor 
experiences of daily living; II. Motor 
experiences of daily living; III. Motor 
examination; IV. Motor complications 
High internal consistency 
(Cronbach’s α= 0.79 – 0.93 
across parts) 
Found to be highly 
correlated with the 
original UPDRS (r=.96)  
Hoehn and 
Yahr28 
0 to 5 Staging scale that provides a general 
estimate of disease severity clinical function in 
PD 5 with 0 indicating that the individual is 
asymptomatic and 5 indicating severely 
impaired postural stability and functional 
mobility. 
Good reliably for moderate 
stages  (2-4)28 
Correlations with β-CIT 
SPECT scanning29 and 
fluorodopa PET 
scanning30 suggesting 
convergent validity 
PDQ-3931,32 
Self-report measure of PD related QOL with 
39 items in 8 sections (mobility, activities of 
daily living, emotional well-being, stigma, 
social support, cognition, communication, 
bodily discomfort). Each item ranges from 0 
(never) to 4 (always).  The mean of each 
section and the overall mean are obtained for 
analysis.  Respondents must affirm one of five 
categories (from never to always), because of 
their PD, they have experienced the problem 
defined by each item during the past month. 
Cronbach’s α= 0.72 – 0.95; 
test-retest reliability .76 – 0.93 
Correlations found with 
BDI>17, MMSE<25, 
history of falls, postural 
instability and gait 
impairments (p < 0.001)  
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Table 3.  Balance and fall domain variables.  
Scale Construct 
Evidence for 
reliability 
Evidence for 
validity 
Falls Efficacy 
Scale (FES)33 
Measure of ones confidence in their 
ability to avoid falling during daily 
activities with 10 items answered on a 
10-point scale.  1 being very confident 
and 10 being not at all confident.  A 
total score of >70 indicates a fear of 
falling  
High internal consistency 
(Cronbach’s  = .90) and 
test retest reliability 
(r=0.71)33 
Concurrent validity with 
ABC scale (r = 0.83)34 
Catastrophizing 
about Falling 
Questionnaire 
(CFQ)35 
Three questions assessing the perceived 
impact that a fall would have on one’s 
functional status answered on a 4 point 
scale.  A score of 12/12 indicates the 
highest degree of catastrophization 
High internal consistency 
(Cronbach’s  = .83)17 
Independent predictor of 
concerns about falling and 
subsequent mobility 
restrictions17  
Impact of Events 
Scale (IES)36,37  
15 item self-report measure to assess 
subjective distress levels related to a 
specific life event.  The total score is the 
overall subjective stress from the event 
(fall/falls).  There are three subscales: 
intrusion (e.g., intrusive thoughts, 
nightmares, intrusive feelings and 
imagery, dissociative-like re-
experiencing), avoidance (e.g., numbing 
of responsiveness, avoidance of 
feelings, situations, and ideas), and 
hyperarousal (e.g., anger, irritability, 
hypervigilance, difficulty concentrating, 
heightened startle). 
High internal consistency 
(Cronbach’s  = .86 for 
intrusion, and Cronbach’s  
= .82 for avoidance)38 
Can discriminate between 
stress reactions at different 
times after an event and 
highly correlates with 
post-traumatic stress 
disorder diagnosis38 
Berg Balance 
Scale (BBS)39 
Clinician-rated assessment of balance 
with 14 tasks.  Scores range from 0 to 
56 with higher scores suggesting better 
balance performance. 
Excellent test-retest 
reliability (ICC = 0.94)40 
and interrater reliability 
(ICC = 0.95 in PD41 
Area under the ROC curve 
(0.851) for predicting fall 
status in those with PD42 
Timed Up and 
Go Test 
(TUGT)43 
A timed test of functional mobility 
consisting of  time it takes to rise from a 
chair, walk three meters, turn around, 
walk back to the chair, and sit down. 
Good test-retest reliability 
in PD (ICCs < 0.80)40,44 and 
excellent interrater 
reliability (r=0.99) in PD45 
Moderate to good 
convergent validity 
evidence in PD (correlated 
with the BBS (r=-0.78), 
Fast gait speed (r=-0.69), 
and comfortable gait 
speed (r=-0.67)46 
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Table 4.  Physical performance domain variables. 
Scale Construct 
Evidence for 
reliability 
Evidence for 
validity 
2 Minute Step 
Test  
(2MST)47  
Functional measure of aerobic 
endurance by counting the number of 
full right knee steps subject make, 
raising each leg to a height midway 
between the patella and iliac crest, in a 
two minute period. 
 
Excellent test-retest 
reliability (ICC=0.95)48 
Able to discriminate 
physically active from 
sedentary older adults48 
and also exercisers and 
nonexercisers47 
ActivPAL 
Activity monitor 
Electronic device measuring five 
components: hours standing, hours 
stepping, hours sitting or lying, up/down 
transitions, and metabolic equivalent of 
tasks  
Inter-device reliability of 
step number and cadence: 
ICC (2,1) ≥ 0.9949 
Absolute percentage of 
error <1% for outdoor 
ambulation, <2% for 
walking speeds of 
<0.67 m/s50 
30 second Sit-to-
Stand Test 
(30STS)47,51 
Assessment of one’s ability to perform 
repeated sit to stands from a chair for 30 
seconds as a measure of functional 
lower extremity strength 
Excellent test-retest 
reliability (ICCs>0.84)48,51 
Able to discriminate 
physically active from 
sedentary older adults48 
and also exercisers and 
nonexercisers47 
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Table 5.  Psychological domain variables. 
Scale Construct 
Evidence for 
reliability 
Evidence for 
validity 
Zung Anxiety 
Scale (ZAS)52 
A self-rating instrument for anxiety 
disorders with 20 items that are 
identified by- a little, some, good part, 
or most of the time. 
Good item-total 
correlations and a 
good test–retest 
reliability in non-PD 
populations53 
In non-PD patients it 
has shown to 
be sensitive to change 
in treatment studies of 
anxiety53 
Beck Depression 
Inventory 
(BDI)54 
 
Most widely used instrument for 
measuring the severity of depression 
based on symptoms from 21-items 
rated by the individual on a 0-3 scale.   
 
 
Cronbach’s  = 
0.88 and  ICC = 
0.89 in patients with 
PD55 
85.67% - 88.0% area 
under the ROC curve 
for distinguishing 
depressed from 
nondepressed in PD55,56 
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APPENDIX B- FIGURES 
Figure 1.  Overall study design.  
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Figure 2. Radar plot of non-avoiders and avoiders on the Movement Disorders Society 
Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) total score and each of the four 
subscales.  
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Figure 3. Radar plot of non-avoiders and avoiders on the Parkinson’s Disease 
Questionnaire – 39 (PDQ-39) total score and each of the eight subscales. 
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Figure 4.  A comparison of non-avoiders and avoiders across three different measures of 
fall history.  
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Figure 5.  Radar plot of non-avoiders and avoiders on measures of balance and related 
issues. 
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Figure 6.  Radar plot of non-avoiders and avoiders on the Impact of Events Scale and 
each of the three subscales. 
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Figure 7. A comparison of non-avoiders and avoiders on three different measures of 
physical performance. 
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Figure 8.  Radar plot of non-avoiders and avoiders on time spent in different daily 
physical activities. 
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Figure 9.  A comparison of non-avoiders and avoiders on anxiety and depression. 
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 Before the Fall- Strength, Balance, and Flexibility: Dr. Sue Schuerman. November 
2012. 
 Pain Management: Dr. John Reneau. November 2012. 
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 NPTA Fall Risk Assessment Presentation: Dr. Jennifer Nash. September 2012.  
 Quantum wheelchair manufacturing facility tour: Las Vegas, Nevada. May 2012. 
 UNLV Physical Therapy Graduate School Class of 2012 Thesis Presentations. May 
2012. 
 Pain Seminar: Dr. Adriaan Louw. February 2012. 
 NPTA Vestibular Rehabilitation Presentation: Dr. Jennifer Nash. February 2012. 
 HIPAA Clinical Care Job Training Completion. January 2012. 
 HIPAA Basics Training Completion. January 2012. 
 CITI Training Completion. January 2012. 
 Rotator Cuff Presentation: Dr. James Detting. November 2011. 
Professional Association Membership 
 American Physical Therapy Association (APTA) member since 2011 
o Memberships: Nevada Chapter, Orthopedic Section, Student Special Interest 
Group 
 American Heart Association Healthcare Provider CPR and AED Certification since 
2010 
o Expires in April 2014 
Professional Leadership 
 UNLV Class of 2014 Curriculum Committee Representative. 2013-2014. 
 UNLV Class of 2014 Class Secretary. 2011-2014. 
Research in Progress 
  Characteristics of subjects who avoid activities and participation due to a fear of falling 
in Parkinson's disease. Student Investigator. 
